Exane Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-206,160
| Closed | -$41.6M | – | 20 |
|
|
2021
Q2 | $41.6M | Buy |
206,160
+50,908
| +33% | +$10.3M | 9.43% | 5 |
|
|
2021
Q1 | $33.4M | Buy |
+155,252
| New | +$33.4M | 12.83% | 2 |
|
|
2018
Q1 | – | Sell |
-1,300
| Closed | -$195K | – | 164 |
|
|
2017
Q4 | $195K | Buy |
1,300
+397
| +44% | +$59.5K | 0.06% | 42 |
|
|
2017
Q3 | $137K | Buy |
+903
| New | +$137K | 0.03% | 85 |
|